verapamil hydrochloride injection, USP Adverse Reactions

()

ADVERSE REACTIONS

The following reactions were reported with verapamil hydrochloride injection used in controlled U.S. clinical trials involving 324 patients:

Cardiovascular: Symptomatic hypotension (1.5%); bradycardia (1.2%); severe tachycardia (1.0%). The worldwide experience in open clinical trials in more than 7,900 patients was similar.

Central Nervous System Effects: Dizziness (1.2%); headache (1.2%). Occasional cases of seizures during verapamil injection have been reported.

Gastrointestinal: Nausea (0.9%); abdominal discomfort (0.6%).

In rare cases of hypersensitive patients, broncho/laryngeal spasm accompanied by itch and urticaria has been reported.

The following reactions have been reported at low frequency: emotional depression, rotary nystagmus, sleepiness, vertigo, muscle fatigue, diaphoresis, and respiratory failure.

*
Actual treatment and dosage should depend on the severity of the clinical situation and the judgment and experience of the treating physician.
Suggested Treatment of Acute Cardiovascular Adverse Reactions*
The frequency of these adverse reactions was quite low, and experience with their treatment has been limited.
Adverse ReactionProven Effective TreatmentSupportive Treatment
1.Symptomatic hypotension requiring treatmentDopamine intravenous
Calcium chloride intravenous
Norepinephrine bitartrate intravenous
Metaraminol bitartrate intravenous
Isoproterenol HCl intravenous
Intravenous fluids
Trendelenburg position
2.Bradycardia, AV block, AsystoleIsoproterenol HCl intravenous
Calcium chloride intravenous
Norepinephrine bitartrate intravenous
Atropine intravenous
Cardiac pacing
Intravenous fluids (slow drip)
3.Rapid ventricular rate (due to antegrade conduction in flutter/fibrillation with W-P-W or L-G-L syndromes)DC-cardioversion (high energy may be required)
Procainamide intravenous
Lidocaine intravenous
Intravenous fluids (slow drip)

Find verapamil hydrochloride injection, USP medical information:

Find verapamil hydrochloride injection, USP medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

verapamil hydrochloride injection, USP Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

Adverse Reactions

ADVERSE REACTIONS

The following reactions were reported with verapamil hydrochloride injection used in controlled U.S. clinical trials involving 324 patients:

Cardiovascular: Symptomatic hypotension (1.5%); bradycardia (1.2%); severe tachycardia (1.0%). The worldwide experience in open clinical trials in more than 7,900 patients was similar.

Central Nervous System Effects: Dizziness (1.2%); headache (1.2%). Occasional cases of seizures during verapamil injection have been reported.

Gastrointestinal: Nausea (0.9%); abdominal discomfort (0.6%).

In rare cases of hypersensitive patients, broncho/laryngeal spasm accompanied by itch and urticaria has been reported.

The following reactions have been reported at low frequency: emotional depression, rotary nystagmus, sleepiness, vertigo, muscle fatigue, diaphoresis, and respiratory failure.

*
Actual treatment and dosage should depend on the severity of the clinical situation and the judgment and experience of the treating physician.
Suggested Treatment of Acute Cardiovascular Adverse Reactions*
The frequency of these adverse reactions was quite low, and experience with their treatment has been limited.
Adverse ReactionProven Effective TreatmentSupportive Treatment
1.Symptomatic hypotension requiring treatmentDopamine intravenous
Calcium chloride intravenous
Norepinephrine bitartrate intravenous
Metaraminol bitartrate intravenous
Isoproterenol HCl intravenous
Intravenous fluids
Trendelenburg position
2.Bradycardia, AV block, AsystoleIsoproterenol HCl intravenous
Calcium chloride intravenous
Norepinephrine bitartrate intravenous
Atropine intravenous
Cardiac pacing
Intravenous fluids (slow drip)
3.Rapid ventricular rate (due to antegrade conduction in flutter/fibrillation with W-P-W or L-G-L syndromes)DC-cardioversion (high energy may be required)
Procainamide intravenous
Lidocaine intravenous
Intravenous fluids (slow drip)

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5Pm ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.